Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.49
$0.128.76%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 60.90% | -93.43% | -49.38% | -66.76% | 77.67% |
Total Receivables | 243.53% | -3.11% | -30.65% | -15.44% | -85.48% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -15.01% | -28.08% | -43.43% | -12.39% | -9.79% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 45.45% | -55.30% | -46.77% | -59.96% | 0.56% |
|
|||||
Total Current Assets | 45.45% | -55.30% | -46.77% | -59.96% | 0.56% |
Net Property, Plant & Equipment | -41.24% | -36.64% | -32.86% | -29.72% | -27.18% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -33.89% | 9.67% | 224.00% | -- | 740.63% |
Total Assets | 34.55% | -48.96% | -42.23% | -55.61% | 7.99% |
|
|||||
Total Accounts Payable | -0.93% | -0.84% | -37.87% | -61.06% | -63.81% |
Total Accrued Expenses | 51.36% | -70.86% | -65.38% | -67.00% | -73.99% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 15.32% | 15.48% | 15.48% | 15.61% | 47.28% |
Total Finance Division Other Current Liabilities | -43.33% | -91.51% | -95.55% | -99.14% | -97.68% |
Total Other Current Liabilities | -43.33% | -91.51% | -95.55% | -99.14% | -97.68% |
Total Current Liabilities | 17.61% | -41.89% | -51.91% | -64.44% | -67.99% |
|
|||||
Total Current Liabilities | 17.61% | -41.89% | -51.91% | -64.44% | -67.99% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -78.74% | -64.40% | -54.19% | -46.48% | -40.55% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 13.75% | -42.41% | -51.96% | -64.05% | -67.39% |
|
|||||
Common Stock & APIC | 9.56% | 6.52% | 6.53% | 5.66% | 22.02% |
Retained Earnings | -8.46% | -6.75% | -7.49% | -8.21% | -14.91% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 56.91% | -114.91% | -23.41% | -43.11% | 172.73% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 56.91% | -114.91% | -23.41% | -43.11% | 172.73% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 56.91% | -114.91% | -23.41% | -43.11% | 172.73% |
|